pancreatic cancer treatment

Read blog posts featuring information and personal perspectives, as well as other materials of interest to the hereditary cancer community, by signing up for our community newsletter.
Education > Our Blog > Tag: pancreatic cancer treatment
Categories
Advanced Search
Subscribe

Your information is used for the sole purpose of sending information about hereditary cancer and updates on FORCE programs and campaigns. To stop receiving these updates, click unsubscribe at the bottom of any email. If you need additional support, or have any questions, please contact [email protected].

Why I Chose Immunotherapy for Pancreatic Cancer

February 07, 2018

Why I Chose Immunotherapy for Pancreatic Cancer

Posted in: Men With Mutations , Cancer Treatment
Tags: BRCA2 , HBOC , Pancreatic Cancer , Cancer Research , Immunotherapy , Immunooncology , Pancreatic Cancer Treatment

Most Recent

Previvor Decisions: Choosing Prophylactic Mastectomy

Results from FORCE’s 2024 Survey Highlighting the Needs of People at High Risk for Breast Cancer

Volunteer Spotlight – Sara Kavanaugh

National Hereditary Cancer Week 2024

Bright Pink and FORCE

New PARP Inhibitor Approval for Pancreatic Cancer

January 06, 2020

New PARP Inhibitor Approval for Pancreatic Cancer

Posted in: XRAY , Cancer Treatment
Tags: Pancreatic Cancer , PARP Inhibitor , Pancreatic Cancer Treatment , Hereditary Pancreatic Cancer

PARP Inhibitor Treatment Is Helping My Pancreatic Cancer

August 24, 2020

PARP Inhibitor Treatment Is Helping My Pancreatic Cancer

Posted in: Stories
Tags: BRCA1 , Pancreatic Cancer , PARP Inhibitor , Pancreatic Cancer Treatment , Men With Mutations

Subscribe to our Blog

Enter your email address to subscribe to this blog and receive a monthly digest of new posts.

Your information is used for the sole purpose of sending information about hereditary cancer and updates on FORCE programs and campaigns. To stop receiving these updates, click unsubscribe at the bottom of any email. If you need additional support, or have any questions, please contact [email protected].